BEYOND
MEDICAL TECHNOLOGIES INC.
Suite 915
– 700 West Pender
Street
Vancouver, BC
V6C
1G8
Canada
VANCOUVER, BC, Feb. 23, 2021 / - Beyond
Medical Technologies Inc. ("Beyond Medical" or the
"Company") (CSE:
DOCT)
(FSE: 7FM4) thru its subsidiary Micron Technologies Inc is
pleased to provide the following corporate update.
THREE PLY MEDICAL GRADE FACE MASKS:
Micron Technologies, the company's wholly owned subsidiary has been
manufacturing and selling medically certified three ply face
masks in the colour blue and also in black since August 2020. The
company is selling out all the inventory that it can manufacture on
three shifts a day and is looking to bring in additional
manufacturing equipment and personnel. Parties wishing to purchase
our masks online can do so at: www.micronti.com
N95 MASKS
There is an ongoing shortage of N95 medical grade masks for
frontline first responders across North America.
Ranvir Gujral stated on NPR
radio "But fewer companies shifted to making N95 masks, which are
far more complicated, and they're in short supply. Nurses and
doctors are re-using masks over and over again. Some small medical
practices can't even find supplies they can
afford"
Micron Technologies has initiated manufacturing of made
in Canada N95 Model 8800 masks at
our state-of-the-art manufacturing facility in Delta, BC.. The
Company is currently manufacturing and distributing under its Class
1 Medical Devices pursuant to the Company's Medical Device
Establishment License from Health Canada and Medical Device
Registration with the US Food and Drug Administration.
The Company's N95 Model 8800 respirators are currently CSA and FDA
approved and undergoing testing and awaiting medical-grade
certification from the National Institute for Occupational Safety
and Health (NIOSH). N95 masks are the gold standard of
personal protective equipment, particularly among healthcare
professionals. They provide the highest level of protection for the
user and those in close proximity to infected patients. N95 masks
are both high in demand and low in supply worldwide. It is the
intent of the Company to have its N95 respirators CSA, FDA and
NIOSH certified and sold to medical professionals and citizens to
help stop the spread of COVID-19.
About Beyond Medical
Beyond Medical is an industrial/technology company with a
manufacturing facility located in Delta, British Columbia. The
Company is developing its Organivore and Pharmavore waste digesters
using its proprietary technology. The Company, through its
subsidiary Micron Technologies, is also manufacturing medical grade
facemasks compliant with ASTM F2100 Standards. Beyond Medical
currently has a non binding LOI to acquire Kayan Health
About Kayan Health
Kayan Health's proprietary AI-powered health communications
platform helps doctors streamline communications with their
patients and remotely monitor them. Additionally, Kayan Health's
proprietary platform allows patients to schedule virtual
consultations with their physicians and communicate with them
through chat, audio and video calls. The platform also integrates
with wearable devices and diagnostic tools that delivers both
patients and doctors with greater visibility into the patient's
health and provides them with proactive automated alerts such as
elevated blood pressure and heart rates. Storing all this data in a
holistic patient profile that is integrated with the clinic's
electronic health systems – ensuring their patients' health records
are up to date, accessible by all, helps deliver better care and
enables clinics to generate more revenue.
Kayan Health's platform has already been deployed in multiple
clinics in the United States and is
projected to reach $5M in revenue by 2022. Kayan
Health's proprietary platform was developed by the founders of
HeyDoc!, a telehealth app launched in 2016 that had supported over
3,000 patients globally. Kayan Health is a privately held company
based in Toronto, Ontario.
Neither the Canadian Securities Exchange
nor its Regulation Services Provider (as that term is defined in
the policies of the Canadian Securities Exchange) accepts
responsibility for the adequacy or accuracy of this
release. The
Canadian Securities Exchange has not in any way passed upon the
merits of the transactions proposed herein and has neither approved
nor disapproved the contents of this press
release.
FORWARD LOOKING
STATEMENTS:
All information contained in this
news release with respect to the Company and Kayan Health was
supplied by the parties, respectively, for inclusion herein, and
the Company and its respective directors and officers have relied
on Kayan Health for any information concerning such party.
This release includes certain
statements that may be deemed "forward-looking statements". All
statements in this release, other than statements of historical
facts, that address events or developments that the Company expects
to occur, are forward-looking statements. Forward-looking
statements are statements that are not historical facts and are
generally, but not always, identified by the words "expects",
"plans", "anticipates", "believes", "intends", "estimates",
"projects", "potential" and similar expressions, or that events or
conditions "will", "would", "may", "could" or "should" occur.
Although the Company believes the expectations expressed in such
forward-looking statements are based on reasonable assumptions,
such statements are not guarantees of future performance and actual
results may differ materially from those in the forward-looking
statements. Factors that could cause the actual results to differ
materially from those in forward-looking statements include market
prices, continued availability of capital and financing, and
general economic, market or business conditions. Investors are
cautioned that any such statements are not guarantees of future
performance and actual results or developments may differ
materially from those projected in the forward-looking
statements.Forward-looking statements are based on the beliefs,
estimates and opinions of the Company's management on the date the
statements are made. Except as required by applicable securities
laws, the Company undertakes no obligation to update these
forward-looking statements in the event that management's beliefs,
estimates or opinions, or other factors, should change.
SOURCE Beyond Medical Technologies Inc
For further information: Kal Malhi, CEO,
604-805-4602, kal@bullruncapital.ca
Related Links
https://micronwaste.com
Beyond Medical Technolog... (CSE:DOCT)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
Beyond Medical Technolog... (CSE:DOCT)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025